TrialBMC infectious diseases2013

Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.

Ying Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.